$DCGO
DocGo Inc. Stock $dcgo

$dcgo Overview Financials Valuation SEC Filings Company Website

2023 Q4 Form 10-Q Financial Statement

#000182235923000032 Filed on November 06, 2023

Income Statement

Concept	2023 Q4	2023 Q3	2022 Q3
Revenue	$199.2M	$186.6M	$104.3M
YoY Change	83.16%	78.83%	21.53%
Cost Of Revenue	$132.6M	$131.5M	$71.25M
YoY Change	99.71%	84.55%
Gross Profit	$66.69M	$55.10M	$33.07M
YoY Change	57.24%	66.64%
Gross Profit Margin	33.47%	29.54%	31.7%
Selling, General & Admin	$43.72M	$35.23M	$22.28M
YoY Change	24.46%	58.13%	6264.83%
% of Gross Profit	65.56%	63.93%	67.37%
Research & Development	$3.185M	$3.235M	$1.373M
YoY Change	85.03%	135.61%	60.67%
% of Gross Profit	4.78%	5.87%	4.15%
Depreciation & Amortization	$4.615M	$1.625M	$1.151M
YoY Change	39.35%	41.21%	92.38%
% of Gross Profit	6.92%	2.95%	3.48%
Operating Expenses	$51.52M	$177.8M	$100.1M
YoY Change	28.29%	77.63%	28505.92%
Operating Profit	$15.17M	$8.708M	$4.199M
YoY Change	573.96%	107.37%	176.4%
Interest Expense	$1.237M	$400.0K	-$1.404M
YoY Change	238.69%	-128.48%	-257.79%
% of Operating Profit	8.15%	4.59%	-33.44%
Other Income/Expense, Net	-$25.04K	$43.35K	$30.90K
YoY Change	-97.57%	40.3%
Pretax Income	$12.20M	$9.157M	$2.868M
YoY Change	-717.02%	219.24%	431.19%
Income Tax	$4.203M	$4.527M	$401.9K
% Of Pretax Income	34.46%	49.44%	14.01%
Net Earnings	$7.570M	$4.630M	$2.466M
YoY Change	-6.13%	87.73%	356.76%
Net Earnings / Revenue	3.8%	2.48%	2.36%
Basic Earnings Per Share		$0.05	$0.03
Diluted Earnings Per Share	$0.07	$0.05	$0.03
COMMON SHARES
Basic Shares Outstanding	103.9M shares	103.8M shares	98.96M shares
Diluted Shares Outstanding		105.0M shares	107.4M shares

Balance Sheet

Concept	2023 Q4	2023 Q3	2022 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments	$59.29M	$52.90M	$169.6M
YoY Change	-62.32%	-68.81%	282564.58%
Cash & Equivalents	$59.29M	$52.92M	$169.6M
Short-Term Investments
Other Short-Term Assets	$17.50M	$6.900M	$2.394M
YoY Change	62.79%	188.18%	941.01%
Inventory
Prepaid Expenses
Receivables	$262.1M	$207.3M	$80.00M
Other Receivables	$0.00	$0.00	$0.00
Total Short-Term Assets	$338.9M	$267.1M	$252.0M
YoY Change	25.01%	6.01%	86794.08%
LONG-TERM ASSETS
Property, Plant & Equipment	$16.84M	$21.85M	$17.58M
YoY Change	-20.8%	24.32%
Goodwill	$47.54M	$47.59M	$34.53M
YoY Change	22.21%	37.82%
Intangibles	$37.68M	$38.59M	$20.65M
YoY Change	64.06%	86.88%
Long-Term Investments	$553.6K	$447.1K	$712.7K
YoY Change	-7.43%	-37.26%	-99.38%
Other Assets	$2.566M	$2.928M	$3.095M
YoY Change	-29.23%	-5.4%
Total Long-Term Assets	$151.6M	$152.6M	$103.9M
YoY Change	24.05%	46.87%	-9.63%
TOTAL ASSETS
Total Short-Term Assets	$338.9M	$267.1M	$252.0M
Total Long-Term Assets	$151.6M	$152.6M	$103.9M
Total Assets	$490.5M	$419.8M	$355.9M
YoY Change	24.71%	17.94%	208.72%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$19.83M	$8.951M	$12.15M
YoY Change	-8.13%	-26.35%	7495.84%
Accrued Expenses	$91.34M	$58.88M	$38.56M
YoY Change	189.3%	52.71%	54982.96%
Deferred Revenue
YoY Change
Short-Term Debt	$25.00M	$0.00	$1.026M
YoY Change		-100.0%
Long-Term Debt Due	$28.13K	$696.1K	$680.7K
YoY Change	-95.77%	2.26%
Total Short-Term Liabilities	$170.1M	$113.1M	$71.14M
YoY Change	69.85%	58.93%	21457.11%
LONG-TERM LIABILITIES
Long-Term Debt	$41.59K	$2.045M	$7.543M
YoY Change	-99.42%	-72.89%
Other Long-Term Liabilities	$7.224M	$7.200M	$6.406M
YoY Change	2.6%	12.39%	-49.24%
Total Long-Term Liabilities	$41.59K	$2.045M	$13.95M
YoY Change	-99.71%	-85.34%	10.53%
TOTAL LIABILITIES
Total Short-Term Liabilities	$170.1M	$113.1M	$71.14M
Total Long-Term Liabilities	$41.59K	$2.045M	$13.95M
Total Liabilities	$185.3M	$128.2M	$85.09M
YoY Change	62.03%	50.71%	557.05%
SHAREHOLDERS EQUITY
Retained Earnings	-$21.39M	-$28.96M	-$37.04M
YoY Change	-26.16%	-21.79%
Common Stock	$10.41K	$10.39K	$10.78K
YoY Change	1.61%	-3.63%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$300.8M	$287.6M	$264.2M
YoY Change
Total Liabilities & Shareholders Equity	$490.5M	$419.8M	$355.9M
YoY Change	24.71%	17.94%	208.72%

Cashflow Statement

Concept	2023 Q4	2023 Q3	2022 Q3
OPERATING ACTIVITIES
Net Income	$7.570M	$4.630M	$2.466M
YoY Change	-6.13%	87.73%	356.76%
Depreciation, Depletion And Amortization	$4.615M	$1.625M	$1.151M
YoY Change	39.35%	41.21%	92.38%
Cash From Operating Activities	-$5.919M	-$45.88M	$7.421M
YoY Change	-32.26%	-718.28%	-4222.54%
INVESTING ACTIVITIES
Capital Expenditures	$3.287M	$1.350M	-$1.993M
YoY Change	112.42%	-167.75%
Acquisitions
YoY Change
Other Investing Activities	$324.4K	-$150.0K	-$33.84M
YoY Change	-63.68%	-99.56%	-338533.7%
Cash From Investing Activities	-$2.962M	-$1.500M	-$35.84M
YoY Change	352.93%	-95.81%	-358458.8%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	12.98M	-8.670M	-436.4K
YoY Change	-289.02%	1886.62%
NET CHANGE
Cash From Operating Activities	-5.919M	-45.88M	7.421M
Cash From Investing Activities	-2.962M	-1.500M	-35.84M
Cash From Financing Activities	12.98M	-8.670M	-436.4K
Net Change In Cash	4.096M	-56.05M	-28.85M
YoY Change	-125.2%	94.27%	16871.61%
FREE CASH FLOW
Cash From Operating Activities	-$5.919M	-$45.88M	$7.421M
Capital Expenditures	$3.287M	$1.350M	-$1.993M
Free Cash Flow	-$9.205M	-$47.23M	$9.413M
YoY Change	-10.5%	-601.75%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
	dei	Entity Central Index Key EntityCentralIndexKey	0001822359
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2023
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q3
	dei	Amendment Flag AmendmentFlag	false
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	157335323	usd
CY2022Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	7818702	usd
CY2022Q4	us-gaap	Receivables Net Current ReceivablesNetCurrent	102995397	usd
CY2023Q3	us-gaap	Assets Of Disposal Group Including Discontinued Operation AssetsOfDisposalGroupIncludingDiscontinuedOperation	0	usd
CY2022Q4	us-gaap	Assets Of Disposal Group Including Discontinued Operation AssetsOfDisposalGroupIncludingDiscontinuedOperation	4480344	usd
CY2023Q3	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	6899412	usd
CY2022Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	6269841	usd
CY2023Q3	us-gaap	Assets Current AssetsCurrent	267146297	usd
CY2022Q4	us-gaap	Assets Current AssetsCurrent	271080905	usd
CY2023Q3	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	21852663	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	21258175	usd
CY2023Q3	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	38586498	usd
CY2022Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	22969246	usd
CY2023Q3	us-gaap	Goodwill Goodwill	47594304	usd
CY2022Q4	us-gaap	Goodwill Goodwill	38900413	usd
CY2023Q3	us-gaap	Restricted Cash Noncurrent RestrictedCashNoncurrent	14333421	usd
CY2022Q4	us-gaap	Restricted Cash Noncurrent RestrictedCashNoncurrent	6773751	usd
CY2023Q3	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	9420525	usd
CY2022Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	9074277	usd
CY2023Q3	us-gaap	Finance Lease Right Of Use Asset FinanceLeaseRightOfUseAsset	8566308	usd
CY2022Q4	us-gaap	Finance Lease Right Of Use Asset FinanceLeaseRightOfUseAsset	9039663	usd
CY2023Q3	us-gaap	Equity Method Investments EquityMethodInvestments	447125	usd
CY2022Q4	us-gaap	Equity Method Investments EquityMethodInvestments	597977	usd
CY2023Q3	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	8908731	usd
CY2022Q4	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	9957967	usd
CY2023Q3	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	2928270	usd
CY2022Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	3625254	usd
CY2023Q3	us-gaap	Assets Assets	419784142	usd
CY2022Q4	us-gaap	Assets Assets	393277628	usd
CY2023Q3	us-gaap	Accounts Payable Current AccountsPayableCurrent	8951261	usd
CY2022Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	21582866	usd
CY2023Q3	us-gaap	Lines Of Credit Current LinesOfCreditCurrent	696053	usd
CY2022Q4	us-gaap	Lines Of Credit Current LinesOfCreditCurrent	664913	usd
CY2022Q4	us-gaap	Liabilities Of Disposal Group Including Discontinued Operation Current LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent	4480344	usd
CY2023Q3	us-gaap	Finance Lease Liability Current FinanceLeaseLiabilityCurrent	2733332	usd
CY2022Q4	us-gaap	Finance Lease Liability Current FinanceLeaseLiabilityCurrent	2732639	usd
CY2023Q3	us-gaap	Long Term Notes Payable LongTermNotesPayable	2044938	usd
CY2022Q4	us-gaap	Long Term Notes Payable LongTermNotesPayable	1236601	usd
CY2022Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	7040982	usd
CY2023Q3	us-gaap	Finance Lease Liability Noncurrent FinanceLeaseLiabilityNoncurrent	5930776	usd
CY2022Q4	us-gaap	Finance Lease Liability Noncurrent FinanceLeaseLiabilityNoncurrent	5914164	usd
CY2023Q3	us-gaap	Liabilities Liabilities	128231727	usd
CY2022Q4	us-gaap	Liabilities Liabilities	114350237	usd
CY2023Q3	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2022Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2023Q3	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	315745338	usd
CY2022Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	301451435	usd
CY2023Q3	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-28964781	usd
CY2022Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-28972216	usd
CY2023Q3	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	808171	usd
CY2022Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	741206	usd
CY2023Q3	us-gaap	Stockholders Equity StockholdersEquity	287599115	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	273230666	usd
CY2023Q3	us-gaap	Minority Interest MinorityInterest	3953300	usd
CY2022Q4	us-gaap	Minority Interest MinorityInterest	5696725	usd
CY2023Q3	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	291552415	usd
CY2022Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	278927391	usd
CY2023Q3	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	419784142	usd
CY2022Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	393277628	usd
CY2022Q3	us-gaap	Revenues Revenues	104319894	usd
	us-gaap	Revenues Revenues	425042373	usd
	us-gaap	Revenues Revenues	331730750	usd
CY2022Q3	dcgo	Cost Of Revenues CostOfRevenues	71254838	usd
	dcgo	Cost Of Revenues CostOfRevenues	296346420	usd
	dcgo	Cost Of Revenues CostOfRevenues	219418873	usd
CY2022Q3	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	22186036	usd
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	93637516	usd
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	70684270	usd
CY2022Q3	us-gaap	Depreciation And Amortization DepreciationAndAmortization	3014864	usd
	us-gaap	Depreciation And Amortization DepreciationAndAmortization	11816657	usd
	us-gaap	Depreciation And Amortization DepreciationAndAmortization	7253656	usd
CY2022Q3	us-gaap	Legal Fees LegalFees	2200964	usd
	us-gaap	Legal Fees LegalFees	9588997	usd
	us-gaap	Legal Fees LegalFees	6610223	usd
CY2022Q3	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	1373146	usd
CY2022Q3	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	90856	usd
	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	2598192	usd
	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	2348917	usd
CY2022Q3	us-gaap	Operating Expenses OperatingExpenses	100120704	usd
	us-gaap	Operating Expenses OperatingExpenses	421661051	usd
CY2023Q3	us-gaap	Unrealized Gain Loss On Derivatives And Commodity Contracts UnrealizedGainLossOnDerivativesAndCommodityContracts	0	usd
CY2022Q3	us-gaap	Unrealized Gain Loss On Derivatives And Commodity Contracts UnrealizedGainLossOnDerivativesAndCommodityContracts	-1831947	usd
	us-gaap	Unrealized Gain Loss On Derivatives And Commodity Contracts UnrealizedGainLossOnDerivativesAndCommodityContracts	0	usd
	us-gaap	Unrealized Gain Loss On Derivatives And Commodity Contracts UnrealizedGainLossOnDerivativesAndCommodityContracts	1137070	usd
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0
	dei	Entity Ex Transition Period EntityExTransitionPeriod	false
	dei	Entity Shell Company EntityShellCompany	false
CY2023Q4	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	103896329	shares
CY2023Q3	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	58883665	usd
CY2022Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	31573031	usd
CY2023Q3	us-gaap	Notes Payable Current NotesPayableCurrent	12995455	usd
CY2022Q4	us-gaap	Notes Payable Current NotesPayableCurrent	26244133	usd
CY2022Q4	us-gaap	Business Combination Contingent Consideration Liability BusinessCombinationContingentConsiderationLiability	10555540	usd
CY2022Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	2325024	usd
CY2023Q3	us-gaap	Liabilities Of Disposal Group Including Discontinued Operation Current LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent	0	usd
CY2023Q3	us-gaap	Liabilities Current LiabilitiesCurrent	113059417	usd
CY2022Q4	us-gaap	Liabilities Current LiabilitiesCurrent	100158490	usd
CY2023Q3	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	7196596	usd
CY2023Q3	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2022Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2022Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	500000000	shares
CY2023Q3	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	500000000	shares
CY2023Q3	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	103874539	shares
CY2022Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	102411162	shares
CY2022Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	102411162	shares
CY2023Q3	us-gaap	Common Stock Value CommonStockValue	10387	usd
CY2022Q4	us-gaap	Common Stock Value CommonStockValue	10241	usd
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	7673269	usd
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	3663299	usd
CY2022Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	4199190	usd
CY2023Q3	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	346376	usd
	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1	-159974	usd
	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1	0	usd
CY2022Q3	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	93371	usd
	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-301362	usd
	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	99840	usd
CY2023Q3	dcgo	Gain Loss Remeasurement Of Finance Leases GainLossRemeasurementOfFinanceLeases	4834	usd
CY2022Q3	dcgo	Gain Loss Remeasurement Of Finance Leases GainLossRemeasurementOfFinanceLeases	0	usd
	dcgo	Gain Loss Remeasurement Of Finance Leases GainLossRemeasurementOfFinanceLeases	4834	usd
	dcgo	Gain Loss Remeasurement Of Finance Leases GainLossRemeasurementOfFinanceLeases	1388273	usd
CY2023Q3	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	-9983	usd
CY2022Q3	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	42667	usd
CY2023Q3	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	43353	usd
CY2022Q3	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	30900	usd
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-661825	usd
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	42288	usd
CY2023Q3	us-gaap	Other Operating Income Expense Net OtherOperatingIncomeExpenseNet	449051	usd
CY2022Q3	us-gaap	Other Operating Income Expense Net OtherOperatingIncomeExpenseNet	-1330788	usd
	us-gaap	Other Operating Income Expense Net OtherOperatingIncomeExpenseNet	715589	usd
CY2023Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	9157006	usd
CY2022Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	2868402	usd
CY2023Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	4526767	usd
CY2022Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	401916	usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	2041843	usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	1163755	usd
	us-gaap	Profit Loss ProfitLoss	23594786	usd
	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	2767084	usd
	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-2924992	usd
CY2022Q3	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	3154430	usd
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-712016	usd
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	26519778	usd
CY2023Q3	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent	-582471	usd
CY2022Q3	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent	248283	usd
	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent	66965	usd
	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent	252854	usd
CY2023Q3	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	4182450	usd
CY2022Q3	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	3402713	usd
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-645051	usd
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	26772632	usd
CY2023Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.05
CY2022Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.03
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.01
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.26
CY2023Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	103874845	shares
CY2022Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	98960538	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	103351345	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	100725697	shares
CY2023Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.05
CY2022Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.03
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.01
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.24
CY2023Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	104993729	shares
CY2022Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	107403135	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	103351345	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	109168293	shares
CY2021Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	227057024	usd
CY2022Q1	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	374344	usd
CY2022Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	1422937	usd
CY2022Q1	dcgo	Stock Issued Effect Of Reverse Acquisition StockIssuedEffectOfReverseAcquisition	-19570	usd
CY2022Q1	us-gaap	Noncontrolling Interest Increase From Subsidiary Equity Issuance NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance	2063000	usd
CY2022Q1	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-5863	usd
CY2022Q1	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-1257257	usd
CY2022Q1	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	10629694	usd
CY2022Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	240264309	usd
CY2022Q2	us-gaap	Stock Repurchased During Period Value StockRepurchasedDuringPeriodValue	497899	usd
CY2022Q2	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	779066	usd
CY2022Q2	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	1999619	usd
CY2022Q2	us-gaap	Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures	82305	usd
CY2022Q2	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-979791	usd
CY2022Q2	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	10434	usd
CY2022Q2	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	12735653	usd
CY2022Q2	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	254393696	usd
CY2022Q3	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	728503	usd
CY2022Q3	dcgo	Share Based Compensation Arrangement By Share Based Payment Award Options Cashless Exercises In Period Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsCashlessExercisesInPeriodValue	-319	usd
CY2022Q3	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	1015660	usd
CY2022Q3	us-gaap	Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures	95543	usd
CY2022Q3	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities StockIssuedDuringPeriodValueConversionOfConvertibleSecurities	12381573	usd
CY2022Q3	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-687944	usd
CY2022Q3	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-248283	usd
CY2022Q3	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	3154430	usd
CY2022Q3	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	270832859	usd
CY2022Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	278927391	usd
CY2023Q1	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	249715	usd
CY2023Q1	us-gaap	Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures	167175	usd
CY2023Q1	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	8181591	usd
CY2023Q1	us-gaap	Gain Loss On Sale Of Business GainLossOnSaleOfBusiness	70284	usd
CY2023Q1	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	243658	usd
CY2023Q2	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	706405	usd
CY2023Q2	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	3827347	usd
CY2023Q2	us-gaap	Adjustments Related To Tax Withholding For Share Based Compensation AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation	2049337	usd
CY2023Q2	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	3354886	usd
CY2023Q2	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	405778	usd
CY2023Q2	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-2011267	usd
CY2023Q2	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	283860579	usd
CY2023Q3	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	426003	usd
CY2023Q3	dcgo	Share Based Compensation Arrangement By Share Based Payment Award Options Cashless Exercises In Period Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsCashlessExercisesInPeriodValue	0	usd
CY2023Q3	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	3335710	usd
CY2023Q3	us-gaap	Adjustments Related To Tax Withholding For Share Based Compensation AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation	117645	usd
CY2023Q3	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-134682	usd
CY2023Q3	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-582471	usd
CY2023Q3	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	4764921	usd
CY2023Q3	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	291552415	usd
	us-gaap	Profit Loss ProfitLoss	2055068	usd
	us-gaap	Profit Loss ProfitLoss	23594786	usd
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	4697717	usd
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	2592244	usd
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	4295958	usd
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	2269423	usd
	us-gaap	Finance Lease Right Of Use Asset Amortization FinanceLeaseRightOfUseAssetAmortization	2822982	usd
	us-gaap	Finance Lease Right Of Use Asset Amortization FinanceLeaseRightOfUseAssetAmortization	2391989	usd
	us-gaap	Gain Loss On Sale Of Other Assets GainLossOnSaleOfOtherAssets	-163452	usd
	us-gaap	Gain Loss On Sale Of Other Assets GainLossOnSaleOfOtherAssets	42667	usd
	us-gaap	Valuation Allowance Deferred Tax Asset Change In Amount ValuationAllowanceDeferredTaxAssetChangeInAmount	-1049236	usd
	us-gaap	Valuation Allowance Deferred Tax Asset Change In Amount ValuationAllowanceDeferredTaxAssetChangeInAmount	0	usd
	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-301362	usd
	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	99840	usd
	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	-311441	usd
	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	2702979	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	15161847	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	4616056	usd
	dcgo	Gain Loss Remeasurement Of Finance Leases GainLossRemeasurementOfFinanceLeases	4834	usd
	dcgo	Gain Loss Remeasurement Of Finance Leases GainLossRemeasurementOfFinanceLeases	1388273	usd
	us-gaap	Gain Loss On Sale Of Business GainLossOnSaleOfBusiness	-70284	usd
	us-gaap	Gain Loss On Sale Of Business GainLossOnSaleOfBusiness	0	usd
	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	0	usd
	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	-1137070	usd
	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1	-159974	usd
	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1	0	usd
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	103483997	usd
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-2894650	usd
	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	-696984	usd
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-12640920	usd
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-3983383	usd
	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	27319258	usd
	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	2596887	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-58303111	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	37607545	usd
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	4360807	usd
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	1994161	usd
	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	2478808	usd
	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	1956434	usd
	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	20203464	usd
	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	33843373	usd
	us-gaap	Payments To Acquire Equity Method Investments PaymentsToAcquireEquityMethodInvestments	150510	usd
	us-gaap	Payments To Acquire Equity Method Investments PaymentsToAcquireEquityMethodInvestments	0	usd
	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment	274210	usd
	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment	0	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-26919379	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-37793968	usd
	us-gaap	Proceeds From Lines Of Credit ProceedsFromLinesOfCredit	0	usd
	us-gaap	Proceeds From Lines Of Credit ProceedsFromLinesOfCredit	1000000	usd
	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	529583	usd
	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	585711	usd
	dcgo	Payments Due To Seller PaymentsDueToSeller	-8417936	usd
	dcgo	Payments Due To Seller PaymentsDueToSeller	-1007800	usd
	us-gaap	Proceeds From Minority Shareholders ProceedsFromMinorityShareholders	0	usd
	us-gaap	Proceeds From Minority Shareholders ProceedsFromMinorityShareholders	2063000	usd
	us-gaap	Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts	0	usd
	us-gaap	Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts	19570	usd
	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	2293330	usd
	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	2146857	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-11858533	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	685871	usd
	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	227887	usd
	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	-252854	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-96853136	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	246594	usd
CY2023Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	67255938	usd
CY2022Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	179352324	usd
	us-gaap	Interest Paid Net InterestPaidNet	179430	usd
	us-gaap	Interest Paid Net InterestPaidNet	102203	usd
	dcgo	Cash Paid For Interest On Finance Lease Liabilities CashPaidForInterestOnFinanceLeaseLiabilities	394443	usd
	dcgo	Cash Paid For Interest On Finance Lease Liabilities CashPaidForInterestOnFinanceLeaseLiabilities	434580	usd
	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	4223810	usd
	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	917445	usd
	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	2407938	usd
	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	4094731	usd
	us-gaap	Noncash Or Part Noncash Acquisition Intangible Assets Acquired1 NoncashOrPartNoncashAcquisitionIntangibleAssetsAcquired1	1500000	usd
	us-gaap	Noncash Or Part Noncash Acquisition Intangible Assets Acquired1 NoncashOrPartNoncashAcquisitionIntangibleAssetsAcquired1	0	usd
CY2023Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	52922517	usd
CY2022Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	169598749	usd
CY2023Q3	us-gaap	Restricted Cash RestrictedCash	14333421	usd
CY2022Q3	us-gaap	Restricted Cash RestrictedCash	9753575	usd
CY2023Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	67255938	usd
CY2022Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	179352324	usd
CY2021Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2021Q4	dcgo	Net Proceeds NetProceeds	158000000	usd
CY2021Q4	dcgo	Cash Held Trust Account CashHeldTrustAccount	43400000	usd
CY2021Q4	dcgo	Underwriters Fees UnderwritersFees	9600000	usd
CY2021Q4	us-gaap	Asset Acquisition Consideration Transferred Transaction Cost AssetAcquisitionConsiderationTransferredTransactionCost	114600000	usd
CY2021Q4	dcgo	Transaction Fees Net TransactionFeesNet	10400000	usd
	us-gaap	Number Of Operating Segments NumberOfOperatingSegments	2	segment
	us-gaap	Stockholders Equity Note Stock Split Conversion Ratio1 StockholdersEquityNoteStockSplitConversionRatio1	645.1452
	us-gaap	Prior Period Reclassification Adjustment Description PriorPeriodReclassificationAdjustmentDescription	<div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Reclassifications</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certain reclassifications of amounts previously reported have been made to the accompanying unaudited Condensed Consolidated Financial Statements to maintain consistency between periods presented. The reclassifications had no impact on previously reported net income or retained earnings.</span></div>
CY2023Q3	us-gaap	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Intangible Assets Other Than Goodwill BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill	29167150	usd
CY2023Q3	us-gaap	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Assets BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets	73638704	usd
CY2023Q3	us-gaap	Cumulative Translation Adjustment Net Of Tax Period Increase Decrease CumulativeTranslationAdjustmentNetOfTaxPeriodIncreaseDecrease	-582471	usd
CY2022Q3	us-gaap	Cumulative Translation Adjustment Net Of Tax Period Increase Decrease CumulativeTranslationAdjustmentNetOfTaxPeriodIncreaseDecrease	248283	usd
	us-gaap	Cumulative Translation Adjustment Net Of Tax Period Increase Decrease CumulativeTranslationAdjustmentNetOfTaxPeriodIncreaseDecrease	66965	usd
	us-gaap	Cumulative Translation Adjustment Net Of Tax Period Increase Decrease CumulativeTranslationAdjustmentNetOfTaxPeriodIncreaseDecrease	252854	usd
	us-gaap	Use Of Estimates UseOfEstimates	<div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Use of Estimates</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of financial statements requires management to make estimates and assumptions that affect the reported amounts of assets, liabilities and expenses and the disclosure of contingent assets and liabilities in its financial statements and the reported amounts of expenses during the reporting period. The most significant estimates in the Company’s financial statements relate to revenue recognition related to the allowance for doubtful accounts, stock-based compensation, calculations related to the incremental borrowing rate for the Company’s lease agreements, estimates related to ongoing lease terms, software development costs, impairment of long-lived assets, goodwill and indefinite-lived intangible assets, business combinations, reserve for losses within the Company’s insurance deductibles, income taxes, and deferred income tax. These estimates and assumptions are based on current facts, historical experience and various other factors believed to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities and the recording of expenses that are not readily apparent from other sources.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Actual results may differ materially and adversely from these estimates. To the extent there are material differences between the estimates and actual results, the Company’s future results of operations could be adversely affected.</span></div>
	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Concentration of Credit Risk and Off-Balance Sheet Risk</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is potentially subject to concentration of credit risk with respect to its cash, cash equivalents and restricted cash, which the Company attempts to minimize by maintaining cash, cash equivalents and restricted cash with institutions of sound financial quality. At times, cash balances may exceed limits federally insured by the Federal Deposit Insurance Corporation (“FDIC”). The Company believes it is not exposed to significant credit risk due to the financial strength of the depository institutions in which the funds are held. The Company has no financial instruments with off-balance sheet risk of loss.</span></div>
	us-gaap	Accumulated Depreciation Depletion And Amortization Sale Of Property Plant And Equipment1 AccumulatedDepreciationDepletionAndAmortizationSaleOfPropertyPlantAndEquipment1	154443	usd
	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment	274210	usd
CY2023Q3	us-gaap	Other Cash Equivalents At Carrying Value OtherCashEquivalentsAtCarryingValue	5434110	usd
CY2022Q4	us-gaap	Other Cash Equivalents At Carrying Value OtherCashEquivalentsAtCarryingValue	8125966	usd
	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	-163452	usd
CY2023Q3	us-gaap	Depreciation Depreciation	1625070	usd
CY2022Q3	us-gaap	Depreciation Depreciation	1150806	usd
CY2022	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	2921958	usd
	us-gaap	Depreciation Depreciation	4697717	usd
	us-gaap	Depreciation Depreciation	2592244	usd
	us-gaap	Payments To Acquire Businesses Gross PaymentsToAcquireBusinessesGross	52979760	usd
CY2023Q3	us-gaap	Revenues Revenues	186552910	usd
CY2022Q3	us-gaap	Revenues Revenues	104319894	usd
	us-gaap	Revenues Revenues	425042373	usd
	us-gaap	Revenues Revenues	331730750	usd
CY2023Q3	us-gaap	Revenues Revenues	186552910	usd
CY2022Q3	us-gaap	Revenues Revenues	104319894	usd
	us-gaap	Revenues Revenues	425042373	usd
	us-gaap	Revenues Revenues	331730750	usd
	us-gaap	Business Combination Consideration Transferred Equity Interests Issued And Issuable BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable	4000000	usd
CY2023Q3	dcgo	Business Combination Deferred Consideration BusinessCombinationDeferredConsideration	17279201	usd
CY2023Q3	us-gaap	Assets Held In Trust AssetsHeldInTrust	1333333	usd
CY2023Q3	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	4764921	usd
CY2022Q3	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	3154430	usd
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-712016	usd
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	26519778	usd
CY2023Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	103874845	shares
CY2022Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	98960538	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	103351345	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	100725697	shares
CY2023Q3	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	1118884	shares
CY2022Q3	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	8442597	shares
	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	1118884	shares
	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	8442597	shares
CY2023Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	104993729	shares
CY2022Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	107403135	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	103351345	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	109168293	shares
CY2023Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.05
CY2022Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.03
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.01
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.26
CY2023Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.05
CY2022Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.03
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.01
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.24
CY2023Q3	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	10191301	shares
CY2022Q3	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	0	shares
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	10191301	shares
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	0	shares
CY2023Q3	dcgo	Business Combination Contingent Consideration Liability Gross BusinessCombinationContingentConsiderationLiabilityGross	26377730	usd
	us-gaap	Business Combination Consideration Transferred1 BusinessCombinationConsiderationTransferred1	101970024	usd
CY2023Q3	us-gaap	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Financial Assets BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedFinancialAssets	9796533	usd
CY2023Q3	us-gaap	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Current Assets Receivables BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables	23264637	usd
CY2023Q3	us-gaap	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Current Assets Other BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther	1761911	usd
CY2023Q3	us-gaap	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Equipment BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedEquipment	9648473	usd
	dcgo	Lessee Lease Term LesseeLeaseTerm	P10Y
CY2023Q3	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	34920871	usd
CY2022Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	29782188	usd
CY2023Q3	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	13068208	usd
CY2022Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	8524013	usd
CY2023Q3	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	21852663	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	21258175	usd
	us-gaap	Property Plant And Equipment Disposals PropertyPlantAndEquipmentDisposals	591184	usd
CY2023Q3	us-gaap	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Current Liabilities Accounts Payable BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable	2288289	usd
CY2023Q3	dcgo	Due To Seller Business Combination DueToSellerBusinessCombination	12377494	usd
CY2023Q3	us-gaap	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Current Liabilities Other BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther	6476000	usd
CY2023Q3	us-gaap	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Liabilities BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities	21141783	usd
CY2023Q3	us-gaap	Business Combination Acquisition Of Less Than100 Percent Noncontrolling Interest Fair Value BusinessCombinationAcquisitionOfLessThan100PercentNoncontrollingInterestFairValue	2567037	usd
	us-gaap	Goodwill Other Increase Decrease GoodwillOtherIncreaseDecrease	42473103	usd
CY2023Q3	us-gaap	Business Combination Recognized Identifiable Assets Acquired Goodwill And Liabilities Assumed Less Noncontrolling Interest BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedLessNoncontrollingInterest	101970024	usd
CY2022	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	2921958	usd
CY2022	us-gaap	Goodwill Acquired During Period GoodwillAcquiredDuringPeriod	35299136	usd
CY2023Q3	us-gaap	Goodwill Goodwill	47594304	usd
CY2022Q4	us-gaap	Goodwill Goodwill	38900413	usd
	us-gaap	Goodwill Acquired During Period GoodwillAcquiredDuringPeriod	8642190	usd
	us-gaap	Goodwill Foreign Currency Translation Gain Loss GoodwillForeignCurrencyTranslationGainLoss	51701	usd
CY2023Q3	us-gaap	Goodwill Goodwill	47594304	usd
CY2023Q3	us-gaap	Intangible Assets Gross Excluding Goodwill IntangibleAssetsGrossExcludingGoodwill	30180863	usd
	dcgo	Intangible Assets Excluding Goodwill Period Increase Decrease IntangibleAssetsExcludingGoodwillPeriodIncreaseDecrease	19908808	usd
CY2023Q3	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	11503173	usd
CY2023Q3	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	38586498	usd
CY2022Q4	us-gaap	Intangible Assets Gross Excluding Goodwill IntangibleAssetsGrossExcludingGoodwill	14731842	usd
CY2022	dcgo	Intangible Assets Excluding Goodwill Period Increase Decrease IntangibleAssetsExcludingGoodwillPeriodIncreaseDecrease	15449021	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	7211617	usd
CY2022Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	22969246	usd
	us-gaap	Finite Lived Intangible Assets Foreign Currency Translation Gain Loss FiniteLivedIntangibleAssetsForeignCurrencyTranslationGainLoss	4402	usd
CY2023Q3	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	1515378	usd
CY2022Q3	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	990345	usd
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	4295958	usd
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	2269423	usd
CY2022Q4	dcgo	Credit Card Payable CreditCardPayable	78838	usd
CY2023Q3	dcgo	Fica Medicare Liability FICAMedicareLiability	29289	usd
CY2022Q4	dcgo	Fica Medicare Liability FICAMedicareLiability	555166	usd
CY2023Q3	us-gaap	Accrued Liabilities Current And Noncurrent AccruedLiabilitiesCurrentAndNoncurrent	58883665	usd
	dcgo	Amortization Expense AmortizationExpense	P5Y
CY2023Q3	us-gaap	Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear	986093	usd
CY2023Q3	us-gaap	Finite Lived Intangible Assets Amortization Expense Next Twelve Months FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths	3896784	usd
CY2023Q3	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Two FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo	3846769	usd
CY2023Q3	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Three FiniteLivedIntangibleAssetsAmortizationExpenseYearThree	3236605	usd
CY2023Q3	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Four FiniteLivedIntangibleAssetsAmortizationExpenseYearFour	3235890	usd
CY2023Q3	dcgo	Finite Lived Intangible Asset Expected Amortization After Year Four FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour	12422803	usd
CY2023Q3	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	27624944	usd
CY2023Q3	dcgo	Accrued Subcontractors AccruedSubcontractors	24121473	usd
CY2022Q4	dcgo	Accrued Subcontractors AccruedSubcontractors	8101150	usd
CY2023Q3	dcgo	Accrued General Expenses AccruedGeneralExpenses	13595062	usd
CY2022Q4	dcgo	Accrued General Expenses AccruedGeneralExpenses	11436462	usd
CY2023Q3	us-gaap	Workers Compensation Liability Current And Noncurrent WorkersCompensationLiabilityCurrentAndNoncurrent	10786533	usd
CY2022Q4	us-gaap	Workers Compensation Liability Current And Noncurrent WorkersCompensationLiabilityCurrentAndNoncurrent	3766469	usd
CY2023Q3	us-gaap	Accrued Payroll Taxes Current AccruedPayrollTaxesCurrent	5707651	usd
CY2022Q4	us-gaap	Accrued Payroll Taxes Current AccruedPayrollTaxesCurrent	4245838	usd
CY2023Q3	us-gaap	Accrued Bonuses Current And Noncurrent AccruedBonusesCurrentAndNoncurrent	1893172	usd
CY2022Q4	us-gaap	Accrued Bonuses Current And Noncurrent AccruedBonusesCurrentAndNoncurrent	1500717	usd
CY2023Q3	dcgo	Accrued Fuel And Maintenance AccruedFuelAndMaintenance	902789	usd
CY2022Q4	dcgo	Accrued Fuel And Maintenance AccruedFuelAndMaintenance	253243	usd
CY2023Q3	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	798826	usd
CY2022Q4	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	706528	usd
CY2023Q3	us-gaap	Accrued Professional Fees Current And Noncurrent AccruedProfessionalFeesCurrentAndNoncurrent	550921	usd
CY2022Q4	us-gaap	Accrued Professional Fees Current And Noncurrent AccruedProfessionalFeesCurrentAndNoncurrent	344417	usd
CY2023Q3	dcgo	Accrued Lab Fees AccruedLabFees	463008	usd
CY2022Q4	dcgo	Accrued Lab Fees AccruedLabFees	584203	usd
CY2023Q3	dcgo	Credit Card Payable CreditCardPayable	34941	usd
CY2022Q4	us-gaap	Accrued Liabilities Current And Noncurrent AccruedLiabilitiesCurrentAndNoncurrent	31573031	usd
CY2022Q4	dcgo	Debt Instrument Number Of Banks With Agreements DebtInstrumentNumberOfBanksWithAgreements	2	bank
CY2022Q4	dcgo	Debt Instrument Number Of Banks Administrative Agent DebtInstrumentNumberOfBanksAdministrativeAgent	1	bank
CY2022Q4	us-gaap	Line Of Credit Facility Maximum Amount Outstanding During Period LineOfCreditFacilityMaximumAmountOutstandingDuringPeriod	90000000	usd
CY2022Q4	us-gaap	Line Of Credit Facility Increase Decrease For Period Net LineOfCreditFacilityIncreaseDecreaseForPeriodNet	50000000	usd
CY2023Q3	dcgo	Installment Amount InstallmentAmount	83823	usd
CY2023Q3	us-gaap	Other Loans Payable OtherLoansPayable	2740991	usd
CY2022Q4	us-gaap	Other Loans Payable OtherLoansPayable	1901514	usd
CY2023Q3	us-gaap	Deposits Received For Securities Loaned At Carrying Value DepositsReceivedForSecuritiesLoanedAtCarryingValue	0	usd
CY2022Q4	us-gaap	Deposits Received For Securities Loaned At Carrying Value DepositsReceivedForSecuritiesLoanedAtCarryingValue	0	usd
CY2023Q3	us-gaap	Notes Payable NotesPayable	2740991	usd
CY2022Q4	us-gaap	Notes Payable NotesPayable	1901514	usd
CY2023Q3	us-gaap	Notes And Loans Payable Current NotesAndLoansPayableCurrent	696053	usd
CY2022Q4	us-gaap	Notes And Loans Payable Current NotesAndLoansPayableCurrent	664913	usd
CY2023Q3	us-gaap	Long Term Notes Payable LongTermNotesPayable	2044938	usd
CY2022Q4	us-gaap	Long Term Notes Payable LongTermNotesPayable	1236601	usd
CY2023Q3	us-gaap	Interest Expense Debt InterestExpenseDebt	48794	usd
CY2022Q3	us-gaap	Interest Expense Debt InterestExpenseDebt	26296	usd
	us-gaap	Interest Expense Debt InterestExpenseDebt	110203	usd
	us-gaap	Interest Expense Debt InterestExpenseDebt	69804	usd
CY2023Q3	us-gaap	Long Term Debt Maturities Repayments Of Principal Remainder Of Fiscal Year LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear	180213	usd
CY2023Q3	us-gaap	Long Term Debt Maturities Repayments Of Principal In Next Twelve Months LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths	672684	usd
CY2023Q3	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Two LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo	678695	usd
CY2023Q3	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Three LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree	623935	usd
CY2023Q3	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Four LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour	428872	usd
CY2023Q3	dcgo	Long Term Debt Maturity After Year Four LongTermDebtMaturityAfterYearFour	156592	usd
CY2023Q3	us-gaap	Long Term Debt LongTermDebt	2740991	usd
CY2023Q3	us-gaap	Long Term Debt Current LongTermDebtCurrent	696053	usd
CY2023Q3	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	2044938	usd
	us-gaap	Number Of Reportable Segments NumberOfReportableSegments	3	segment
CY2022	us-gaap	Number Of Operating Segments NumberOfOperatingSegments	2	segment
CY2022	dcgo	Number Of Revenue Streams NumberOfRevenueStreams	2	revenuestream
	us-gaap	Number Of Reportable Segments NumberOfReportableSegments	3	segment
CY2023Q3	us-gaap	Revenues Revenues	186552910	usd
CY2023Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	8707955	usd
CY2023Q3	us-gaap	Assets Assets	419784142	usd
CY2023Q3	us-gaap	Depreciation And Amortization DepreciationAndAmortization	4336267	usd
CY2023Q3	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	3360710	usd
CY2023Q3	us-gaap	Noncurrent Assets NoncurrentAssets	126020298	usd
CY2023Q3	us-gaap	Payments To Acquire Productive Assets PaymentsToAcquireProductiveAssets	5492705	usd
CY2022Q3	us-gaap	Revenues Revenues	104319894	usd
CY2022Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	4199190	usd
CY2022Q3	us-gaap	Assets Assets	355920210	usd
CY2022Q3	us-gaap	Depreciation And Amortization DepreciationAndAmortization	3014864	usd
CY2022Q3	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	1111203	usd
CY2022Q3	us-gaap	Noncurrent Assets NoncurrentAssets	90365726	usd
CY2022Q3	us-gaap	Payments To Acquire Productive Assets PaymentsToAcquireProductiveAssets	17353534	usd
	us-gaap	Revenues Revenues	425042373	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	3381322	usd
CY2023Q3	us-gaap	Assets Assets	419784142	usd
	us-gaap	Depreciation And Amortization DepreciationAndAmortization	11816657	usd
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	15161847	usd
CY2023Q3	us-gaap	Noncurrent Assets NoncurrentAssets	126020298	usd
	us-gaap	Payments To Acquire Productive Assets PaymentsToAcquireProductiveAssets	47728959	usd
	us-gaap	Revenues Revenues	331730750	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	21751512	usd
CY2022Q3	us-gaap	Assets Assets	355920210	usd
	us-gaap	Depreciation And Amortization DepreciationAndAmortization	7253656	usd
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	4533759	usd
CY2022Q3	us-gaap	Noncurrent Assets NoncurrentAssets	90365726	usd
	us-gaap	Payments To Acquire Productive Assets PaymentsToAcquireProductiveAssets	20110289	usd
CY2023Q3	us-gaap	Noncurrent Assets NoncurrentAssets	126020298	usd
CY2022Q3	us-gaap	Noncurrent Assets NoncurrentAssets	90365726	usd
CY2022Q2	us-gaap	Stock Repurchase Program Authorized Amount1 StockRepurchaseProgramAuthorizedAmount1	40000000	usd
CY2022Q4	us-gaap	Treasury Stock Shares Acquired TreasuryStockSharesAcquired	536839	shares
CY2022Q2	us-gaap	Treasury Stock Shares Acquired TreasuryStockSharesAcquired	536839	shares
CY2022Q4	us-gaap	Treasury Stock Value Acquired Cost Method TreasuryStockValueAcquiredCostMethod	3731712	usd
CY2022Q2	us-gaap	Treasury Stock Value Acquired Cost Method TreasuryStockValueAcquiredCostMethod	3731712	usd
	us-gaap	Treasury Stock Shares Acquired TreasuryStockSharesAcquired	0	shares
	dcgo	Share Based Compensation Arrangement By Share Based Payment Award Options Granted Contractual Term ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantedContractualTerm	P10Y
CY2023Q3	dcgo	Share Based Compensation Arrangement By Share Based Payment Award Option Vested And Expected To Vest Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionVestedAndExpectedToVestExercisableNumber	2900000	shares
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Minimum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum	0.0410
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Maximum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum	0.0487
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Minimum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum	0.07
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Maximum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum	2.80
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P6Y3M
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P4Y
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Minimum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum	0.52
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Maximum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum	0.62
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Minimum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum	0.60
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Maximum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum	0.64
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	11571308	shares
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	7.11
CY2022	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P9Y18D
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	39389063	usd
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	1115874	shares
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	8.92
	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	493984	shares
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	3.63
	dcgo	Share Based Compensation Arrangement By Share Based Payment Award Options Cancelled In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsCancelledInPeriod	551665	shares
	dcgo	Share Based Compensation Arrangements By Share Based Payment Award Options Cancelled In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsCancelledInPeriodWeightedAverageExercisePrice	7.66
CY2023Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	11641533	shares
CY2023Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	7.42
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P8Y5M19D
CY2023Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	49268644	usd
CY2023Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber	2937143	shares
CY2023Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice	6.36
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1	P7Y7M24D
CY2023Q3	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1	3060026	usd
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	8.92
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	7.04
CY2023Q3	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions	30994529	usd
CY2022Q4	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions	41666564	usd
	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1 EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1	P1Y10M6D
	us-gaap	Operating Lease Cost OperatingLeaseCost	2319282	usd
	us-gaap	Lease Cost LeaseCost	2380857	usd
CY2023Q3	us-gaap	Operating Lease Payments OperatingLeasePayments	697050	usd
CY2023Q3	dcgo	Financing Lease Payments FinancingLeasePayments	782808	usd
CY2022Q3	us-gaap	Operating Lease Payments OperatingLeasePayments	626188	usd
CY2019Q1	us-gaap	Subordinated Borrowing Interest Rate SubordinatedBorrowingInterestRate	0.06
CY2023Q3	us-gaap	Operating Lease Cost OperatingLeaseCost	697050	usd
CY2022Q3	us-gaap	Operating Lease Cost OperatingLeaseCost	626188	usd
	us-gaap	Operating Lease Cost OperatingLeaseCost	2319282	usd
	us-gaap	Operating Lease Cost OperatingLeaseCost	1517541	usd
CY2023Q3	us-gaap	Short Term Lease Cost ShortTermLeaseCost	452538	usd
CY2022Q3	us-gaap	Short Term Lease Cost ShortTermLeaseCost	334619	usd
	us-gaap	Short Term Lease Cost ShortTermLeaseCost	1156886	usd
	us-gaap	Short Term Lease Cost ShortTermLeaseCost	863316	usd
CY2023Q3	us-gaap	Lease Cost LeaseCost	1149588	usd
CY2022Q3	us-gaap	Lease Cost LeaseCost	960807	usd
	us-gaap	Lease Cost LeaseCost	3476168	usd
	us-gaap	Lease Cost LeaseCost	2380857	usd
CY2023Q3	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	9420525	usd
CY2022Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	9074277	usd
CY2023Q3	dcgo	Operating Lease Assets OperatingLeaseAssets	9420525	usd
CY2022Q4	dcgo	Operating Lease Assets OperatingLeaseAssets	9074277	usd
CY2023Q3	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	2561165	usd
CY2022Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	2325024	usd
CY2023Q3	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	7196596	usd
CY2022Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	7040982	usd
CY2023Q3	us-gaap	Operating Lease Liability OperatingLeaseLiability	9757761	usd
CY2022Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	9366006	usd
CY2023Q3	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P4Y4M9D
CY2023Q3	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.0576
CY2023Q3	us-gaap	Lessee Operating Lease Liability Payments Remainder Of Fiscal Year LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear	813120	usd
CY2023Q3	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	2987762	usd
CY2023Q3	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	2982487	usd
CY2023Q3	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	2183265	usd
CY2023Q3	us-gaap	Lessee Operating Lease Liability Payments Due Year Four LesseeOperatingLeaseLiabilityPaymentsDueYearFour	1090802	usd
CY2023Q3	dcgo	Lessee Operating Lease Liability Payments Due After Year Four LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFour	862023	usd
CY2023Q3	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	10919459	usd
CY2023Q3	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	1161698	usd
CY2023Q3	us-gaap	Operating Lease Liability OperatingLeaseLiability	9757761	usd
CY2023Q3	us-gaap	Operating Lease Cost OperatingLeaseCost	697050	usd
CY2022Q3	us-gaap	Lease Cost LeaseCost	960807	usd
CY2022Q3	dcgo	Financing Lease Payments FinancingLeasePayments	672975	usd
	us-gaap	Operating Lease Payments OperatingLeasePayments	2319282	usd
	dcgo	Financing Lease Payments FinancingLeasePayments	2293330	usd
	us-gaap	Operating Lease Payments OperatingLeasePayments	1517541	usd
	dcgo	Financing Lease Payments FinancingLeasePayments	2146587	usd
CY2023Q3	us-gaap	Finance Lease Liability FinanceLeaseLiability	8664108	usd
CY2022Q4	us-gaap	Finance Lease Liability FinanceLeaseLiability	8646803	usd
CY2023Q3	dcgo	Accumulated Depreciation AccumulatedDepreciation	10701206	usd
CY2022Q4	dcgo	Accumulated Depreciation AccumulatedDepreciation	7096966	usd
CY2023Q3	dcgo	Depreciation Expenses DepreciationExpenses	1195719	usd
CY2022Q3	dcgo	Depreciation Expenses DepreciationExpenses	873713	usd
	dcgo	Depreciation Expenses DepreciationExpenses	2822982	usd
	dcgo	Depreciation Expenses DepreciationExpenses	2391989	usd
CY2022Q2	dcgo	Gain Loss Remeasurement Of Finance Leases GainLossRemeasurementOfFinanceLeases	1400000	usd
CY2023Q3	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	782808	usd
CY2022Q3	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	672975	usd
	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	2293330	usd
	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	2146857	usd
CY2023Q3	us-gaap	Short Term Lease Payments ShortTermLeasePayments	0	usd
CY2022Q3	us-gaap	Short Term Lease Payments ShortTermLeasePayments	0	usd
	us-gaap	Short Term Lease Payments ShortTermLeasePayments	0	usd
	us-gaap	Short Term Lease Payments ShortTermLeasePayments	0	usd
CY2023Q3	us-gaap	Lease Income LeaseIncome	782808	usd
CY2022Q3	us-gaap	Lease Income LeaseIncome	672975	usd
	us-gaap	Lease Income LeaseIncome	2293330	usd
	us-gaap	Lease Income LeaseIncome	2146857	usd
CY2023Q3	us-gaap	Finance Lease Right Of Use Asset FinanceLeaseRightOfUseAsset	8566308	usd
CY2022Q4	us-gaap	Finance Lease Right Of Use Asset FinanceLeaseRightOfUseAsset	9039663	usd
CY2023Q3	dcgo	Finance Lease Assets FinanceLeaseAssets	8566308	usd
CY2022Q4	dcgo	Finance Lease Assets FinanceLeaseAssets	9039663	usd
CY2023Q3	us-gaap	Finance Lease Liability Current FinanceLeaseLiabilityCurrent	2733332	usd
CY2022Q4	us-gaap	Finance Lease Liability Current FinanceLeaseLiabilityCurrent	2732639	usd
CY2023Q3	us-gaap	Finance Lease Liability Noncurrent FinanceLeaseLiabilityNoncurrent	5930776	usd
CY2022Q4	us-gaap	Finance Lease Liability Noncurrent FinanceLeaseLiabilityNoncurrent	5914164	usd
CY2023Q3	us-gaap	Finance Lease Liability FinanceLeaseLiability	8664108	usd
CY2022Q4	us-gaap	Finance Lease Liability FinanceLeaseLiability	8646803	usd
CY2023Q3	us-gaap	Finance Lease Weighted Average Remaining Lease Term1 FinanceLeaseWeightedAverageRemainingLeaseTerm1	P3Y6M29D
CY2023Q3	us-gaap	Finance Lease Weighted Average Discount Rate Percent FinanceLeaseWeightedAverageDiscountRatePercent	0.0596
CY2023Q3	us-gaap	Finance Lease Liability Payments Remainder Of Fiscal Year FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear	867050	usd
CY2023Q3	us-gaap	Finance Lease Liability Payments Due Next Twelve Months FinanceLeaseLiabilityPaymentsDueNextTwelveMonths	3018851	usd
CY2023Q3	us-gaap	Finance Lease Liability Payments Due Year Two FinanceLeaseLiabilityPaymentsDueYearTwo	2740288	usd
CY2023Q3	us-gaap	Finance Lease Liability Payments Due Year Three FinanceLeaseLiabilityPaymentsDueYearThree	1969492	usd
CY2023Q3	us-gaap	Finance Lease Liability Payments Due Year Four FinanceLeaseLiabilityPaymentsDueYearFour	850883	usd
CY2023Q3	dcgo	Finance Lease Liability To Be Paid After Year Four FinanceLeaseLiabilityToBePaidAfterYearFour	114107	usd
CY2023Q3	us-gaap	Finance Lease Liability Payments Due FinanceLeaseLiabilityPaymentsDue	9560671	usd
CY2023Q3	us-gaap	Finance Lease Liability Undiscounted Excess Amount FinanceLeaseLiabilityUndiscountedExcessAmount	896563	usd
CY2023Q3	us-gaap	Finance Lease Liability FinanceLeaseLiability	8664108	usd
CY2023Q3	us-gaap	Other Operating Income Expense Net OtherOperatingIncomeExpenseNet	449051	usd
CY2022Q3	us-gaap	Other Operating Income Expense Net OtherOperatingIncomeExpenseNet	-1330788	usd
	us-gaap	Other Operating Income Expense Net OtherOperatingIncomeExpenseNet	715589	usd
	us-gaap	Other Operating Income Expense Net OtherOperatingIncomeExpenseNet	3007029	usd
CY2023Q3	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	346376	usd
CY2022Q3	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	334221	usd
	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	1677420	usd
	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	296891	usd
CY2023Q3	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	0	usd
CY2022Q3	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	1831947	usd
	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	0	usd
	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	-1137070	usd
CY2023Q3	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1	-159974	usd
CY2022Q3	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1	0	usd
	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1	-159974	usd
	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1	0	usd
CY2023Q3	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-95503	usd
CY2022Q3	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	93371	usd
	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-301362	usd
	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	99840	usd
CY2023Q3	dcgo	Gain Loss Remeasurement Of Finance Leases GainLossRemeasurementOfFinanceLeases	4834	usd
CY2022Q3	dcgo	Gain Loss Remeasurement Of Finance Leases GainLossRemeasurementOfFinanceLeases	0	usd
	dcgo	Gain Loss Remeasurement Of Finance Leases GainLossRemeasurementOfFinanceLeases	4834	usd
	dcgo	Gain Loss Remeasurement Of Finance Leases GainLossRemeasurementOfFinanceLeases	1388273	usd
CY2023Q3	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	-9983	usd
CY2022Q3	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	42667	usd
	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	-163452	usd
	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	42667	usd
CY2023Q3	us-gaap	Gain Loss Related To Litigation Settlement GainLossRelatedToLitigationSettlement	0	usd
CY2022Q3	us-gaap	Gain Loss Related To Litigation Settlement GainLossRelatedToLitigationSettlement	0	usd
	us-gaap	Gain Loss Related To Litigation Settlement GainLossRelatedToLitigationSettlement	-1000000	usd
	us-gaap	Gain Loss Related To Litigation Settlement GainLossRelatedToLitigationSettlement	0	usd
CY2023Q3	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	43353	usd
CY2022Q3	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	30900	usd
	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	338175	usd
	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	42288	usd
CY2023Q3	us-gaap	Other Operating Income Expense Net OtherOperatingIncomeExpenseNet	449051	usd
CY2022Q3	us-gaap	Other Operating Income Expense Net OtherOperatingIncomeExpenseNet	-1330788	usd
	us-gaap	Other Operating Income Expense Net OtherOperatingIncomeExpenseNet	715589	usd
	us-gaap	Other Operating Income Expense Net OtherOperatingIncomeExpenseNet	3007029	usd
CY2023Q3	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	43353	usd
CY2023Q3	us-gaap	Foreign Currency Transaction Gain Loss Realized ForeignCurrencyTransactionGainLossRealized	924	usd
CY2023Q3	us-gaap	Rental Income Nonoperating RentalIncomeNonoperating	26	usd
CY2022Q3	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	30900	usd
CY2022Q3	us-gaap	Foreign Currency Transaction Gain Loss Realized ForeignCurrencyTransactionGainLossRealized	777	usd
CY2022Q3	us-gaap	Rental Income Nonoperating RentalIncomeNonoperating	30123	usd
	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	338175	usd
	us-gaap	Foreign Currency Transaction Gain Loss Realized ForeignCurrencyTransactionGainLossRealized	6697	usd
	us-gaap	Rental Income Nonoperating RentalIncomeNonoperating	8522	usd
	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	42288	usd
	us-gaap	Foreign Currency Transaction Gain Loss Realized ForeignCurrencyTransactionGainLossRealized	-18883	usd
	us-gaap	Rental Income Nonoperating RentalIncomeNonoperating	61171	usd
CY2023Q3	us-gaap	Payments For Commissions PaymentsForCommissions	204700	usd
CY2022Q3	us-gaap	Payments For Commissions PaymentsForCommissions	261185	usd
	us-gaap	Payments For Commissions PaymentsForCommissions	674970	usd
	us-gaap	Payments For Commissions PaymentsForCommissions	704593	usd
CY2023Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	4526767	usd
CY2022Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	401916	usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	2041843	usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	1163755	usd
	dcgo	Defined Contribution Plan Eligibility Service Period DefinedContributionPlanEligibilityServicePeriod	P2M
CY2023Q3	ecd	Rule10b51 Arr Adopted Flag Rule10b51ArrAdoptedFlag	false
CY2023Q3	ecd	Non Rule10b51 Arr Adopted Flag NonRule10b51ArrAdoptedFlag	false
CY2023Q3	ecd	Non Rule10b51 Arr Trmntd Flag NonRule10b51ArrTrmntdFlag	false
CY2023Q3	ecd	Rule10b51 Arr Trmntd Flag Rule10b51ArrTrmntdFlag	false

Files In Submission

Name	View Source	Status
dcgo-20230930_cal.xml	Edgar Link	unprocessable
dcgo-20230930_pre.xml	Edgar Link	unprocessable
dcgo-20230930_lab.xml	Edgar Link	unprocessable
0001822359-23-000032-index-headers.html	Edgar Link	pending
0001822359-23-000032-index.html	Edgar Link	pending
0001822359-23-000032.txt	Edgar Link	pending
0001822359-23-000032-xbrl.zip	Edgar Link	pending
dcgo-20230930.htm	Edgar Link	pending
dcgo-20230930.xsd	Edgar Link	pending
dcgo-20230930xexx102.htm	Edgar Link	pending
dcgo-20230930xexx311.htm	Edgar Link	pending
dcgo-20230930xexx312.htm	Edgar Link	pending
dcgo-20230930xexx32.htm	Edgar Link	pending
dcgo-20230930xexx321.htm	Edgar Link	pending
dcgo-20230930xexx322.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
dcgo-20230930_def.xml	Edgar Link	unprocessable
FilingSummary.xml	Edgar Link	unprocessable
dcgo-20230930_htm.xml	Edgar Link	completed
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R70.htm	Edgar Link	pending
R71.htm	Edgar Link	pending
R72.htm	Edgar Link	pending
R73.htm	Edgar Link	pending
R74.htm	Edgar Link	pending
R75.htm	Edgar Link	pending
R76.htm	Edgar Link	pending
R77.htm	Edgar Link	pending
R78.htm	Edgar Link	pending
R79.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R80.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$DCGO
DocGo Inc. Stock $dcgo

2023 Q4 Form 10-Q Financial Statement

#000182235923000032 Filed on November 06, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$DCGO DocGo Inc. Stock $dcgo

2023 Q4 Form 10-Q Financial Statement

#000182235923000032 Filed on November 06, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$DCGO
DocGo Inc. Stock $dcgo